Prognostic Significance of Abnormal -catenin Expression in BreastCarcinoma
Prognostic Significance of Abnormal -catenin Expression in Breast Carcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background : The subcellular localization and activity of β-catenin are tightly regulated within the cell. The aim of this study was to analyze the aberrant β-catenin expression in breast carcinomas and to determine its clinical significance. Methods : Fifty five cases of breast carcinoma were immunostained with monoclonal antibodies against β-catenin. Normal expression of β-catenin was defined as exclusive membranous staining. Abnormal expression of β-catenin was reclassified into 3 categories: complete or partial loss of membranous staining (LOM) without cytoplasmic staining and nuclear staining, LOM with cytoplasmic staining and without nuclear staining, and LOM with nuclear staining and with/without cytoplasmic staining. Results : Normal membranous β-catenin expression was detected in 25 (45.5%) of 55 cases of breast carcinoma. Thirty cases with abnormal β-catenin expression comprised 9 cases (16.1%) showing LOM without cytoplasmic and/or nuclear staining, 20 cases (36.4%) showing LOM with cytoplasmic staining and without nuclear staining, and one case (1.8%) showing LOM with nuclear and cytoplasmic staining. Abnormal β-catenin expression was significantly correlated with lymph node metastasis (p=0.03). LOM with cytoplasmic and/or nuclear expression was significantly correlated with poor disease free survival by univariate (p=0.03) and multivariate analyses (p=0.03). In addition, it was correlated with poor overall survival with a borderline significance (p=0.059). Conclusions : This study suggests that the cytoplasmic and/or nuclear expression of β-catenin can be used as a biologic marker for predicting disease recurrence and poor patients' survival in breast carcinomas.
참고문헌 (23)
- "Oncogenic pathwaysin hereditary and sporadic breast cancer", 49, pp.34~43 (2004)
- "Functional correlation between cell adhesive proportionsand some cell surface proteins", 75, pp.464~74 (1977)
- "Cadherin cell adhesion receptors as a morphogeneticregulator", 251, pp.1451~5 (1991)
- "Wnt family proteins in mammary developmentand cancer", 9, pp.119~31 (2004)
- "Beta-catenin and Tcfsin mammary development and cancer", 8, pp.145~58
- "Wnt signaling and mammary tumorigenesis", 6, pp.37~52 (2001)
- "Constitutive transcriptional activationby a beta-catenin-Tcf complex in APC-", -colon carcinoma, 1997, pp.275, 1784~7
- "Regulationof intercellular beta-catenin levels by adenomatous polyposis coli(APC)tumor-suppressor protein", 92, pp.3046~50 (1995)
- "Mutational analysisof the APC", beta-catenin, pp.1998, 58[DOI]
- "Prognostic significance of E-cadherinand beta-catenin in resected stage I non-small cell lung cancer", 24, pp.441~9 (2003)
- "Increased beta-catenin mRNAlevels and mutational alterations of the APC and beta-catenin geneare present in intestinal-type gastric cancer", 23, pp.87~91 (2002)
- "Mutation and altered expression ofbeta-catenin during gallbladder carcinogenesis", 26, pp.758~66
- "beta-catenin nuclear localizationis associated with grade in ovarian serous carcinoma", 88, pp.363~8 (2003)
- "Histological grading of breastcarcinomas:a study of interobserver agreement", 26, pp.873~9 (1995)
- "Beta-catenin,a novel prognostic markerfor breast cancer:its roles in cyclin D1 expression and cancer progression", 97, pp.4262~6 (2000)
- "Pin1 regulates turnoverand subcellular localization of beta-catenin by inhibiting itsinteraction with APC", 3, pp.793~801 (2001)
- "Gene expression profiling of breastcancers with emphasis of beta-catenin regulation", 19, pp.275~82
- "Wnt signaling and breast cancer", 3, pp.36~41 (2004)
- "Beta-catenin and p53 analysesof a breast carcinoma tissue microarray", 100, pp.2084~92 (2004)
- "Deregulatedbeta-catenin induces a p53- and ARF-dependent growth arrestand cooperates with Ras in transformation", 20, pp.4912~22 (2001)
- "Deficiency of p53 acceleratesmammary tumorigenesis in Wnt-1 transgenic mice and promoteschromosomal instability", 9, pp.882~95 (1995)
- "Siah-1,SIP,and Ebi collaborate in a novelpathway for beta-catenin degradation linked to p53 responses", 7, pp.915~26 (2001)
- "Siah-1 mediates a novel beta-catenindegradation pathway linking p53 to the adenomatous polyposis coliprotein", 7, pp.927~36 (2001)
